HOME
|
CONTACT US
|
REFERENCES
The African American Heart Failure Trial (A-HeFT) was terminated early following a recommendation from the independent Data Safety Monitoring Board due to a significantly lower mortality rate in the BiDil group.
1
,
4
BiDil Home
Health Care Provider
Home
About BiDil
History of Development
Heart Failure in African Americans
A-HeFT
Efficacy
BiDil vs. ISDN and Hydralazine
Mechanism of Action
Prescribing Information
Dosing & Administration
Important Safety Information
Coverage & Assistance
Formulary status
Programs
Clinical Resources
Request Samples
Patient/Caregiver
Home
About Heart Failure
What is Heart Failure?
Prevention and Common Symptoms
Tests for Heart Failure
Risk in African Americans
Medicines for Treating Heart Failure
Surgical Procedures for Heart Failure
About BiDil
Tips & Tools
What You Can Do
Follow Doctor's Orders
Stay Informed
Live Heart-Healthy
Other Resources
Coverage & Assistance
Formulary status
Programs
Patient Resources
Success Stories
Common Questions
PRIVACY NOTICE
LEGAL NOTICE
SITE MAP
Copyright © 2009 NitroMed, Inc. All Rights Reserved.